DIETary Intake, Death and Hospitalization in Adult With End-stage Kidney Disease Treated With HemoDialysis (DIET-HD) Study
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The DIETary intake, death and hospitalisation in adults with end-stage kidney disease treated with HaemoDialysis (DIET-HD) study is a multinational prospective cohort study designed to evaluate the association between nutrition and dietary patterns and health outcomes in prevalent adult haemodialysis patients in Europe and South America.
Condition or disease
Diet HabitEnd Stage Renal Disease
Other: dietary intake of omega-3 and omega-6 polyunsaturated fatty acids
Cardiovascular mortality [ Time Frame: 12 months since baseline dietary evaluation ]
Defined as sudden death or death attributed to acute myocardial infarction, pericarditis, atherosclerotic heart disease, cardiomyopathy, cardiac arrhythmia, cardiac arrest, valvular heart disease, pulmonary edema, or congestive cardiac failure
Secondary Outcome Measures :
All-cause mortality [ Time Frame: 12 months since baseline dietary evaluation ]
Infection-related mortality [ Time Frame: 12 months since baseline dietary evaluation ]
All-cause and cardiovascular related hospitalisation [ Time Frame: 12 months since baseline dietary evaluation ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
dialysis clinics administered by a single dialysis provider
End-stage kidney disease
Long-term haemodialysis for at least the previous 90 days
18 years or older
Treating team agrees to the patient's involvement in the study
Participant willing to provide written and informed consent.-
significant neurocognitive disability or medical comorbidity that would preclude them from understanding the dietary questionnaire even if assisted
a life expectancy less than 6 months according to their treating physician
planned kidney transplantation within 6 months of baseline